Suki vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Suki ambient AI scribe serves 400+ health systems (4x growth in 2024), generates $1,223/month incremental revenue per provider; raised $168M including $70M Series D and Zoom Ventures (2024).
About
Suki is an AI-powered healthcare technology company founded in 2017 by Punit Soni (ex-Google/Motorola VP), headquartered in Redwood City, California. Its AI scribe listens to clinician-patient conversations and auto-generates structured notes, coding suggestions, and clinical orders. Raised $168M total including a $70M Series D (October 2024) and Zoom Ventures investment (January 2025).
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.